ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00487123
Recruitment Status : Completed
First Posted : June 15, 2007
Last Update Posted : June 17, 2008
Sponsor:
Information provided by:
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2007
  Actual Study Completion Date : September 2007